Safety and Tolerability Cerebrolysin: Well-Established Safety Profile Cerebrolysin benefits from decades of post-marketing surveillance and clinical trial safety data: Clinical Trial Safety: Across multiple RCTs, Cerebrolysin has demonstrated a tolerability profile comparable to placebo in most studies, with adverse events generally mild and transient Common Side Effects: Injection site reactions, dizziness, headache, and nausea are the most frequently reported adverse events at standard clinical doses Serious Adverse Events: Rare at therapeutic doses
S., Kodanaz, A
Thus far, the only detailed data available on the use of the peptide comes from a single group in Russia, albeit from a well-respected one
Song YM, Lee WK, Lee Y-h, Kang ES, Cha B-S, Lee B-W
Symptoms of favism include fever, stomach pain, and jaundice and can occur within hours of consuming fava beans
It is one of the most extensively studied pentadecapeptides in published research literature, frequently referenced in tissue repair, gastrointestinal signalling, and angiogenesis research models
